listed · IPO · NSE SME · listed 29 May 2026
Q-Line Biotech Limited
Raised ₹214.48 Cr at ₹343 per share.
+31.8%
listing-day move
Price band
₹326 – ₹343
Issue price
₹343
Issue size
₹214.48 Cr
Return since listing
+38.37%
Company research
Source: Tijori Finance · third-party enrichmentAbout the company
Q-Line Biotech Limited, incorporated in 2010, is engaged in developing, manufacturing, and marketing diagnostic reagents, kits, consumables, and IVD equipment for healthcare applications, serving diagnostic laboratories, hospitals, and medical colleges across multiple pathology segments.
Financials (₹ crore)
| Period | Revenue | PAT | Debt |
|---|---|---|---|
| Mar 2023 | 182.74 Cr | 32.1 Cr | 73.65 Cr |
| Mar 2024 | 203.65 Cr | 34.45 Cr | 96.91 Cr |
| Mar 2025 | 313.78 Cr | 28.13 Cr | 166.29 Cr |
Revenue mix
Reagent (kits and POC devices) 68.8%
Instrument 27.2%
Consumable/Spare 3.0%
Service 1.0%
Peer comparison
| Company | Mkt cap (Cr) | Revenue | PAT | P/E | P/B |
|---|---|---|---|---|---|
| QLINE | 0 | 313 Cr | 28.13 Cr | — | — |
| POLYMED | 13,467 | 1,669 Cr | 338 Cr | 41.8 | 4.34 |
| TARSONS | 1,141 | 392 Cr | 29.77 Cr | 79.65 | 1.8 |
| MOREPENLAB | 2,313 | 1,811 Cr | 118 Cr | 24.38 | 1.86 |
| NURECA | 263 | 109 Cr | 0.85 Cr | 24.75 | 1.32 |
Exchange filings
Fields captured from NSE and BSEIssue information
- Symbol
- QLINE
- Issue period
- 2026-05-21 to 2026-05-25
- Price range
- Rs.326 to Rs.343
- Red Herring Prospectus
- https://nsearchives.nseindia.com/emerge/corporates/content/QLineBiotechLimited_RHP.zip
Data sources: MONEYCONTROL , NSE , NSE , NSE . Data quality clean.